Apr 27, 2020
Global Pandemic Consortium supports Trump's call for investigation of ultraviolet light as a potential treatment for COVID 19
Feb 04, 2020
Apheresis Market Worth $2.7 Billion by 2025 - Exclusive Report by MarketsandMarkets(TM)
Feb 04, 2020
Apheresis Market Worth $2.7 Billion by 2025 - Exclusive Report by MarketsandMarkets(TM)
Oct 31, 2019
Mallinckrodt Announces UVADEX® (Methoxsalen) Approved in Australia for use with the THERAKOS® CELLEX® Photopheresis System for Treatment of Chronic Graft Versus Host Disease (cGvHD) and Skin Manifestations of Cutaneous T-Cell Lymphoma (CTCL) in Adults
Mar 26, 2019
Mallinckrodt Announces 2019 Investigator Award for Pioneering Efforts in ECP Immunomodulation
Feb 25, 2019
Mallinckrodt Announces Extracorporeal Photopheresis Research Collaboration Agreement With Transimmune AG
Feb 20, 2019
Mallinckrodt Announces Interim Analysis Results for Therakos® Platform Phase 3 Clinical Trial in Treatment of Pediatric Patients with Steroid Refractory Acute Graft-versus-Host Disease
Feb 19, 2019
Job Research Foundation Makes Scientific Advisory Board Appointments: Prof. Alain Fischer, MD as Chief Scientific Officer, Prof. Andrew R. Gennery, MD Named to Board
Jul 05, 2018
Apheresis Equipment (2016-2024) Global Strategic Business Report 2018 - Rising Cancer Incidence to Drive Volume of Apheresis Procedures
Mar 20, 2018
Mallinckrodt Announces First Investigator Award for Pioneering Efforts in ECP Immunomodulation
Sep 05, 2017
Apheresis Equipment Market will grow at 11.4% CAGR till 2024
Jun 05, 2017
Apheresis Market to Reach US$4.33 Billion by 2025: High Demand for Plasma Exchange Procedures in Neurology and Hematology to Boost Growth, Says TMR